wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38734040-1D8BCF8F-FC9B-46D4-97EA-2DD170213F8D
Q38734040-1D8BCF8F-FC9B-46D4-97EA-2DD170213F8D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38734040-1D8BCF8F-FC9B-46D4-97EA-2DD170213F8D
Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.
P2860
Q38734040-1D8BCF8F-FC9B-46D4-97EA-2DD170213F8D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38734040-1D8BCF8F-FC9B-46D4-97EA-2DD170213F8D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3c55dd622d64e7b407759bf6d2be8b3cd6616fd5
P2860
PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.